Janney initiated coverage of Independent Bank Group with a rating of Neutral
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 5/31/2024 | $38.00 → $58.00 | Underweight → Overweight | Piper Sandler |
| 4/24/2024 | $53.00 → $46.00 | Market Perform | Hovde Group |
| 4/24/2024 | $48.00 → $38.00 | Neutral → Underweight | Piper Sandler |
| 1/5/2024 | $56.00 | Mkt Perform → Outperform | Raymond James |
| 7/26/2023 | $40.00 → $44.00 | Overweight → Neutral | Piper Sandler |
| 10/26/2022 | $82.50 → $70.00 | Outperform → Market Perform | Hovde Group |
| 3/9/2022 | Neutral | Janney | |
| 1/26/2022 | $80.00 → $85.00 | Buy | Truist Securities |
SC 13G/A - Independent Bank Group, Inc. (0001564618) (Subject)
SC 13G/A - Independent Bank Group, Inc. (0001564618) (Subject)
SC 13G/A - Independent Bank Group, Inc. (0001564618) (Subject)
Expands Presence in TX & CO and Adds Three Board Members WINTER HAVEN, Fla., Jan. 2, 2025 /PRNewswire/ -- SouthState Corporation (NYSE:SSB) ("SouthState" or the "Company") today announced the closing of its acquisition of Independent Bank Group, Inc. (NASDAQ:IBTX) ("Independent Financial") on January 1, 2025, through the merger of Independent Financial with and into SouthState. Immediately after the merger, also on January 1, 2025, Independent Financial's subsidiary bank, Independent Bank, merged with and into SouthState Bank, N.A. ("SouthState Bank"). As a result of these transactions, the combined company has expanded its presence in Texas, entered Colorado, and increased its asset size to
NEW YORK, Dec. 30, 2024 /PRNewswire/ -- Acadia Pharmaceuticals Inc. (NASD: ACAD) will replace Independent Bank Group Inc. (NASD: IBTX) in the S&P SmallCap 600 effective prior to the opening of trading on Friday, January 3, 2025. S&P MidCap 400 constituent SouthState Corp. (NYSE:SSB) is acquiring Independent Bank Group in a deal expected to close soon pending final conditions. Following is a summary of the change that will take place prior to the open of trading on the effective date: Effective Date Index Name Action Company Name Ticker GICS Sector Jan 3, 2025 S&P SmallCap 600 Addition Acadia Pharmaceuticals ACAD Health Care Jan 3, 2025 S&P SmallCap 600 Deletion Independent Bank Group
Independent Bank Group, Inc. (NASDAQ:IBTX) today announced net income of $20.4 million, or $0.49 per diluted share, for the quarter ended September 30, 2024, compared to $32.8 million, or $0.79 per diluted share for the quarter ended September 30, 2023 and net loss of $493,455 or ($11.93) per diluted share for the quarter ended June 30, 2024. Adjusted (non-GAAP) net income for the quarter ended September 30, 2024 was $20.6 million, or $0.50 per diluted share, compared to $32.6 million, or $0.79 per diluted share for the quarter ended September 30, 2023 and $24.9 million, or $0.60 per diluted share for the quarter ended June 30, 2024. The Company also announced that its Board of Directors d
Expands Presence in TX & CO and Adds Three Board Members WINTER HAVEN, Fla., Jan. 2, 2025 /PRNewswire/ -- SouthState Corporation (NYSE:SSB) ("SouthState" or the "Company") today announced the closing of its acquisition of Independent Bank Group, Inc. (NASDAQ:IBTX) ("Independent Financial") on January 1, 2025, through the merger of Independent Financial with and into SouthState. Immediately after the merger, also on January 1, 2025, Independent Financial's subsidiary bank, Independent Bank, merged with and into SouthState Bank, N.A. ("SouthState Bank"). As a result of these transactions, the combined company has expanded its presence in Texas, entered Colorado, and increased its asset size to
NEW YORK, Dec. 30, 2024 /PRNewswire/ -- Acadia Pharmaceuticals Inc. (NASD: ACAD) will replace Independent Bank Group Inc. (NASD: IBTX) in the S&P SmallCap 600 effective prior to the opening of trading on Friday, January 3, 2025. S&P MidCap 400 constituent SouthState Corp. (NYSE:SSB) is acquiring Independent Bank Group in a deal expected to close soon pending final conditions. Following is a summary of the change that will take place prior to the open of trading on the effective date: Effective Date Index Name Action Company Name Ticker GICS Sector Jan 3, 2025 S&P SmallCap 600 Addition Acadia Pharmaceuticals ACAD Health Care Jan 3, 2025 S&P SmallCap 600 Deletion Independent Bank Group
Independent Bank Group, Inc. (NASDAQ:IBTX) today announced net income of $20.4 million, or $0.49 per diluted share, for the quarter ended September 30, 2024, compared to $32.8 million, or $0.79 per diluted share for the quarter ended September 30, 2023 and net loss of $493,455 or ($11.93) per diluted share for the quarter ended June 30, 2024. Adjusted (non-GAAP) net income for the quarter ended September 30, 2024 was $20.6 million, or $0.50 per diluted share, compared to $32.6 million, or $0.79 per diluted share for the quarter ended September 30, 2023 and $24.9 million, or $0.60 per diluted share for the quarter ended June 30, 2024. The Company also announced that its Board of Directors d
Piper Sandler upgraded Independent Bank Group from Underweight to Overweight and set a new price target of $58.00 from $38.00 previously
Hovde Group reiterated coverage of Independent Bank Group with a rating of Market Perform and set a new price target of $46.00 from $53.00 previously
Piper Sandler downgraded Independent Bank Group from Neutral to Underweight and set a new price target of $38.00 from $48.00 previously
4 - Independent Bank Group, Inc. (0001564618) (Issuer)
4 - Independent Bank Group, Inc. (0001564618) (Issuer)
4 - Independent Bank Group, Inc. (0001564618) (Issuer)
15-12G - Independent Bank Group, Inc. (0001564618) (Filer)
15-12G - Independent Bank Group, Inc. (0001564618) (Filer)
15-12G - Independent Bank Group, Inc. (0001564618) (Filer)
WINTER HAVEN, Fla. and MCKINNEY, Texas, May 20, 2024 /PRNewswire/ -- SouthState Corporation (NYSE:SSB) ("SouthState") and Independent Bank Group, Inc. (NASDAQ:IBTX) ("Independent Bank Group") jointly announced today that they have entered into a definitive agreement under which SouthState will acquire Independent Bank Group, in an all-stock transaction valued at approximately $2 billion. Independent Bank Group, based in McKinney, Texas, has approximately $18.9 billion in total assets, $15.7 billion in total deposits and $14.6 billion in total loans as of March 31, 2024, and op
Independent Bank Group, Inc. (NASDAQ:IBTX) today announced net income of $24.2 million, or $0.58 per diluted share, for the quarter ended March 31, 2024, compared to $14.9 million, or $0.36 per diluted share for the quarter ended December 31, 2023. Adjusted (non-GAAP) net income for the quarter ended March 31, 2024 was $26.0 million, or $0.63 per diluted share, compared to $25.5 million, or $0.62 per diluted share for the quarter ended December 31, 2023. The Company also announced that its Board of Directors declared a quarterly cash dividend of $0.38 per share of common stock. The dividend will be payable on May 16, 2024 to stockholders of record as of the close of business on May 2, 202
Independent Bank Group, Inc. (NASDAQ:IBTX), the holding company for Independent Financial, will hold a conference call to discuss first quarter 2024 results on Tuesday, April 23, 2024, at 8:30 am ET. The related press release will be issued Monday, April 22, 2024, after 4:00 pm ET. Conference Call Details The call can be accessed by the webcast link, https://www.webcast-eqs.com/indepbankgroupq12024_en/en, or by calling 1-877-407-0989 and by identifying the meeting number 13745780 or by identifying "Independent Bank Group First Quarter 2024 Earnings Conference Call". The conference materials will also be available by accessing the Investor Relations page of our website, www.ifinancial.co